Octreotide sc depot provides sustained octreotide bioavailability and similar IGF-1 suppression to octreotide LAR in healthy volunteers.

Fredrik Tiberg; John Roberts; Camilla Cervin; Markus Johnsson; Severine Sarp; Anadya Prakash Tripathi; Margareta Linden

doi:10.1111/bcp.12698

Octreotide sc depot provides sustained octreotide bioavailability and similar IGF-1 suppression to octreotide LAR in healthy volunteers.

Fredrik Tiberg, John Roberts, Camilla Cervin, Markus Johnsson, Severine Sarp, Anadya Prakash Tripathi, Margareta Linden

Research output: Contribution to journal › Article › peer-review

Abstract

To assess the pharmacokinetics, pharmacodynamics, safety, and tolerability of octreotide subcutaneous (sc) depot, a novel octreotide formulation.

Original language	English
Pages (from-to)	460-472
Journal	British Journal of Clinical Pharmacology
Volume	80
Issue number	3
DOIs	https://doi.org/10.1111/bcp.12698
Publication status	Published - 2015

Subject classification (UKÄ)

Pharmacology and Toxicology

Access to Document

10.1111/bcp.12698

http://www.ncbi.nlm.nih.gov/pubmed/26076191?dopt=Abstract

Cite this

@article{01fd1213c5b54f8fb9e2696353d06d9b,

title = "Octreotide sc depot provides sustained octreotide bioavailability and similar IGF-1 suppression to octreotide LAR in healthy volunteers.",

abstract = "To assess the pharmacokinetics, pharmacodynamics, safety, and tolerability of octreotide subcutaneous (sc) depot, a novel octreotide formulation.",

author = "Fredrik Tiberg and John Roberts and Camilla Cervin and Markus Johnsson and Severine Sarp and Tripathi, {Anadya Prakash} and Margareta Linden",

year = "2015",

doi = "10.1111/bcp.12698",

language = "English",

volume = "80",

pages = "460--472",

journal = "British Journal of Clinical Pharmacology",

issn = "1365-2125",

publisher = "John Wiley & Sons Inc.",

number = "3",

}

TY - JOUR

T1 - Octreotide sc depot provides sustained octreotide bioavailability and similar IGF-1 suppression to octreotide LAR in healthy volunteers.

AU - Tiberg, Fredrik

AU - Roberts, John

AU - Cervin, Camilla

AU - Johnsson, Markus

AU - Sarp, Severine

AU - Tripathi, Anadya Prakash

AU - Linden, Margareta

PY - 2015

Y1 - 2015

N2 - To assess the pharmacokinetics, pharmacodynamics, safety, and tolerability of octreotide subcutaneous (sc) depot, a novel octreotide formulation.

AB - To assess the pharmacokinetics, pharmacodynamics, safety, and tolerability of octreotide subcutaneous (sc) depot, a novel octreotide formulation.

U2 - 10.1111/bcp.12698

DO - 10.1111/bcp.12698

M3 - Article

SN - 1365-2125

VL - 80

SP - 460

EP - 472

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

IS - 3

ER -

Octreotide sc depot provides sustained octreotide bioavailability and similar IGF-1 suppression to octreotide LAR in healthy volunteers.

Abstract

Subject classification (UKÄ)

Access to Document

Fingerprint

Cite this